Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma-Reference-Cited by-同舟云学术

Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma

Published:2022-11 Issue: Volume:176 Page:13-29
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Moehler Markus,Högner Anica,Wagner Anna D.^ORCID,Obermannova Radka,Alsina Maria,Thuss-Patience Peter^ORCID,van Laarhoven Hanneke^ORCID,Smyth Elizabeth

Funder

Berlin Mathematical School

Merck

Sanofi-Aventis Deutschland

Roche

Servier

Bayer

GlaxoSmithKline

Merck KGaA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference78 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

3. Novel HER2-directed treatments in advanced gastric carcinoma: AnotHER paradigm shift?;Ricci;Cancers,2021

4. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study;Shitara;Lancet Oncol,2019

5. Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (Pts) with advanced/metastatic HER2+ gastric cancer (GC)/Gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03;Janjigian;J Clin Orthod,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma;JAMA Network Open;2024-01-23

2. Development and Preclinical Evaluation of [68Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression;Pharmaceuticals;2023-10-19

3. Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects;International Journal of Molecular Sciences;2023-10-18

4. Immune regulation in gastric adenocarcinoma is linked with therapeutic efficacy and improved recovery;Frontiers in Genetics;2023-08-11

5. Immunotherapy for gastroesophageal cancer;Oncology in Clinical Practice;2023-06-29